# TargED Biopharmaceuticals: Research, Utrecht, Netherlands

> TargED Biopharmaceuticals: TargED Biopharmaceuticals is a clinical-stage biotechnology company based in Utrecht, Netherlands. Based in Utrecht, Netherlands.

Source: https://millionrounds.com/startup/targed-biopharmaceuticals (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Research startup](https://millionrounds.com/companies)

# TargED Biopharmaceuticals

TargED Biopharmaceuticals is a clinical-stage biotechnology company based in Utrecht, Netherlands.

Email

Funding reported Last round: Series A

Research Utrecht, Netherlands

Follow TargED Biopharmaceuticals and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Ftarged-biopharmaceuticals)

Company summary

- **Founded:** 2018 8 years old
- **Team:** 38 11 to 50 people
- **Funding reported:** 40.4M as listed, currency not stated
- **Last round:** Series A Feb 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for TargED Biopharmaceuticals has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About TargED Biopharmaceuticals

TargED Biopharmaceuticals is a clinical-stage biotechnology company based in Utrecht, Netherlands.

Founded in July 2020 as a spin-off from the University Medical Center Utrecht, TargED focuses on developing innovative biological drugs to enhance the treatment of thrombosis, which includes blood clots. The company utilizes a proprietary technology called Targeted Enzyme Delivery, employing small antibody fragments to deliver clot-dissolving enzymes directly to thrombus sites, allowing for precise treatment with reduced side effects. The lead compound, TGD001 (also known as MICROLYSE), targets proteins involved in various thrombotic disorders, including Immune Thrombotic Thrombocytopenic Purpura (iTTP) and Acute Ischemic Stroke (AIS). TargED aims to address critical unmet needs in thrombotic disease treatment and has raised over €45 million in funding to support its mission. The company is committed to advancing therapies for patients suffering from thrombosis and is actively working towards securing market authorization for its innovative solutions.

## What company datasets say TargED Biopharmaceuticals raised

Funding, as reported

Reported in all **40.4M** in the source's currency

Rounds **2**

Last round **Series A**

Last round size **44.4M**

Last round date **Feb 2022**

Investors listed **8**

## Founders and team

From TargED Biopharmaceuticals's own website: 5 on the team.

- **Kristof Vercruysse** Chief Executive Officer
- **Filip Van den Wyngaert** Vice President Asset Management
- **Dr. Samuel White** Chief Business Officer
- **Josi Holz** Chief Medical Officer
- **Steven de Maat** Chief Scientific Officer

## On 5 portfolio pages

Investors who name them

- [Fund+](https://millionrounds.com/fund/fundplus)
- [Andera Partners](https://millionrounds.com/fund/andera-partners)
- [Inkef](https://millionrounds.com/fund/inkef-capital)
- [Rotrip Europe B.V.](https://millionrounds.com/fund/rotrip-europe-b-v)
- [Curie Capital](https://millionrounds.com/fund/curie-capital)

Each firm lists TargED Biopharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

biotechnology research medical thrombolysis biologicals pharmaceuticals pharmaceutical manufacturing microvascular thrombosis

Built with from their website

Google Maps WordPress.org Font Awesome Viewport Meta Varnish OpenAI Apple Business Manager Underscore.js Priority Hints CAPTCHA

+8 more

Microsoft Exchange MySQL PrimeNG Microsoft 365 Apps & Services Mobile Friendly Open Graph jQuery Lua

- **Sector:** Research
- **Region:** Utrecht
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/targed-biopharmaceuticals)

## Research in Netherlands

Startups like it

- [**Citryll** Oss · founded 2015 *Raised*](https://millionrounds.com/company/citryll)
- [**Leyden Labs** Leiden · founded 2020 *Raised*](https://millionrounds.com/company/leyden-labs)
- [**NorthSea Therapeutics** Amsterdam · founded 2017 *Raised*](https://millionrounds.com/company/northsea-therapeutics)
- [**Synerkine Pharma** Leiden · founded 2018 *Raised*](https://millionrounds.com/company/synerkine-pharma)
- [**ENPICOM** 's-Hertogenbosch · founded 2015 *Raised*](https://millionrounds.com/company/enpicom)
- [**PHOSPHOENIX** Amsterdam · founded 2019 *Raised*](https://millionrounds.com/company/phosphoenix)
- [**AZAFAROS B.V.** Naarden · founded 2018](https://millionrounds.com/startup/azafaros-b-v)
- [**VectorY** Amsterdam · founded 2020](https://millionrounds.com/startup/vectory)

## Is this your company?

Add your raise, your deck and your story, and put TargED Biopharmaceuticals in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)